Next |
home / stock / meip / meip message board
Subject | By | Source | When |
---|---|---|---|
Out. May recover but R/S concern is | kzivann | investorshub | 12/06/2022 2:46:15 PM |
Doing a little. Risking a part of | kzivann | investorshub | 12/06/2022 12:56:43 PM |
Whats your take on Today thinking if loading | INFINITI | investorshub | 12/06/2022 12:53:43 PM |
Lead drug. FDA issue. Continuing trails in | kzivann | investorshub | 12/06/2022 12:48:06 PM |
Why did it drop so much | INFINITI | investorshub | 12/06/2022 12:42:39 PM |
Bidding now. A little below current bid. | kzivann | investorshub | 12/06/2022 12:28:41 PM |
Oops bottom cat bounce here | INFINITI | investorshub | 12/06/2022 11:10:39 AM |
Biotin cat bounce here | INFINITI | investorshub | 12/06/2022 11:10:24 AM |
znewcar1: $MEIP 26% v6,4M c.4149 f133,26M H.43 ML.28 S.3205 lod | znewcar1 | investorshangout | 12/02/2022 11:08:31 PM |
Good move Friday $$$ | kzivann | investorshub | 12/02/2022 7:27:28 PM |
Who the fuck is selling all those shares.... institutions? | rudyboy | investorshub | 10/17/2022 4:31:57 PM |
Little flips add up. | kzivann | investorshub | 09/14/2022 1:05:18 PM |
https://www.meipharma.com/sites/meipharma-corp/files/2022-09/meip-2022-earn | dfrank1988 | investorshub | 09/09/2022 4:04:33 PM |
Again. | kzivann | investorshub | 07/22/2022 5:15:59 PM |
$MEIP - MEI Pharma, Inc. (NASDAQ:$MEIP) Shares Purchased | DD-214 | investorshub | 07/11/2022 12:56:02 PM |
whytestocks: $MEIP News Article - MEI Pharma Appoints Human Resources Executive Anne Frese as Chief | whytestocks | investorshangout | 06/22/2022 8:10:56 PM |
I had a buddy tell me to buy | CAN8IENS | investorshub | 06/08/2022 12:51:44 AM |
Nice move. | kzivann | investorshub | 06/07/2022 6:49:06 PM |
Next huuuuge runner!!! | Jess070283 | investorshub | 06/07/2022 6:47:41 PM |
Keeps going up. | kzivann | investorshub | 06/07/2022 2:55:26 PM |
News, Short Squeeze, Breakout and More Instantly...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital, Prioritizing Measured Investment, Extending Operational Runway – MEI Pharma, Inc. ...
– Cohort 1 Exceeds Predetermined Non-Progression Threshold in the Ongoing Phase 1b Study – – ME-344 in Combination with Bevacizumab was Generally Well-tolerated with no Evidence of Overlapping Toxicity – – MEI to Continue Advancing ME-344 via Dev...
MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David Urso, president and chief executive officer of MEI Pharma, will participate in a firesi...